Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CDC6 is a prognostic biomarker and correlated with immune infiltrates in glioma

25 Jul 2022

Abstract excerpt

BACKGROUND: Cell division cycle 6 (CDC6) has been proven to be associated with the initiation and progression of human multiple tumors. However, it's role in glioma, which is ranked as one of the common primary malignant tumor in the central nervous system and is associated with high morbidity and mortality, is unclear. METHODS: In this study, we explored CDC6 gene expression level in pan-cancer. Furthermore, we...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Immune cells in cancer
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35879762
DOI: 10.1186/s12943-022-01623-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CDC6 is a prognostic biomarker and correlated with immune infiltrates in gliomaPMID 35879762Read ↗

CDC42—A promising immune-related target in gliomaSemantic proximity Read ↗

A pan-cancer analysis reveals the diagnostic and prognostic role of CDCA2 in low-grade gliomaSemantic proximity Read ↗

Integrated bioinformatics analysis and experimental validation identified CDCA families as prognostic biomarkers and sensitive indicators for rapamycin treatment of gliomaSemantic proximity Read ↗

FNDC3B is a Potential Prognostic Biomarker and Correlated With Immune Infiltrates in GliomaSemantic proximity Read ↗

Identification of NEK6 as a potential biomarker for prognosis in gliomaSemantic proximity Read ↗

Comprehensive analysis of m6A/m5C/m1A-related gene expression, immune infiltration, and sensitivity of antineoplastic drugs in gliomaSemantic proximity Read ↗

Increased Expression of CDCA2 in Glioma Predicts Poor Prognosis as Identified by Population-based AnalysisSemantic proximity Read ↗

Detection of immune-related cells and genes in the glioma tumor microenvironment from the CGGA database using bioinformatics strategiesSemantic proximity Read ↗

Systematic Identification of UBE2C As a Prognostic Biomarker and Correlated with Immunosuppression and Invasiveness in GliomaSemantic proximity Read ↗

CMTM6 overexpression is associated with molecular and clinical characteristics of malignancy and predicts poor prognosis in gliomasSemantic proximity Read ↗

Multi-omics analyses of CD276 in pan-cancer reveals its clinical prognostic value in glioblastoma and other major cancer typesSemantic proximity Read ↗

High Expression of PRMT6 Associated With Prognosis and Immune Infiltration in GliomaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.